Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

783
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
783
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

245
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
245

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted long-read sequencing enables comprehensive analysis of the genetic and epigenetic landscape of inherited myopathies.

Nature communications·2026
Same author

Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes.

BMJ neurology open·2026
Same author

Reduced electroencephalogram power and no change in peak alpha frequency in individuals with chronic migraine: a cross-sectional investigation.

Neurophysiologie clinique = Clinical neurophysiology·2026
Same author

Methylmalonic acid: a new target for Hadamard-edited MRS.

bioRxiv : the preprint server for biology·2026
Same author

Characterising the association between posterior parietal metabolite levels and cortical macrostructure in a cohort spanning childhood to adulthood.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same journal

Altered hypothalamic metabolism in chronic cluster headaches patients measured with <sup>1</sup>H-MRS at ultra-high magnetic field.

The journal of headache and pain·2026
Same journal

Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

The journal of headache and pain·2026
Same journal

Trigeminovascular calcitonin gene-related peptide release and peripheral vascular responses in a mouse model of accelerated aging: Implications for migraine.

The journal of headache and pain·2026
Same journal

Cerebrovascular reactivity in migraine: a breath-hold BOLD fMRI study.

The journal of headache and pain·2026
Same journal

Profile of migraine patients in Middle East and North Africa (MENA) region: a multi-center study.

The journal of headache and pain·2026
Same journal

CXCL10 knockdown attenuates vestibular migraine in rats by inhibiting PI3K-mediated neuroinflammation and central sensitization.

The journal of headache and pain·2026
See all related articles

Related Experiment Video

Updated: Oct 10, 2025

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.0K

Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time.

Aimie L Peek1,2, Andrew M Leaver3, Sheryl Foster3,4

  • 1Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, 2141, Australia. apee6909@uni.sydney.edu.au.

The Journal of Headache and Pain
|December 14, 2021
PubMed
Summary
This summary is machine-generated.

Elevated Gamma-aminobutyric acid + macromolecules (GABA+) levels in the anterior cingulate cortex may be a protective response to migraine, not a cause. Improvements in migraine symptoms correlated with increased GABA+ levels, suggesting a compensatory mechanism.

Keywords:
Anti-CGRPGABALongitudinalMRSMigrainePain

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.4K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.0K

Related Experiment Videos

Last Updated: Oct 10, 2025

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

1.0K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.4K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

4.0K

Area of Science:

  • Neuroscience
  • Neuroimaging
  • Chronic Pain Research

Background:

  • An imbalance in brain neurometabolites is linked to chronic pain conditions like migraine.
  • Previous magnetic resonance spectroscopy (MRS) studies reported elevated Gamma-aminobutyric acid + macromolecules (GABA+) in individuals with migraine.
  • The causal relationship between elevated GABA+ and migraine pathophysiology remains unclear.

Purpose of the Study:

  • To investigate the dynamic changes in brain GABA+ levels in individuals with chronic migraine.
  • To determine if GABA+ levels fluctuate in response to clinical changes in migraine characteristics over time.
  • To elucidate whether elevated GABA+ is a cause or consequence of chronic migraine.

Main Methods:

  • A 3-month observational study of 18 individuals with chronic migraine (ICHD-3) undergoing treatment escalation.
  • Magnetic resonance spectroscopy (MRS) scans were performed at baseline and follow-up.
  • Migraine frequency, intensity (HIT-6), and disability (WHODAS) were assessed using questionnaires.

Main Results:

  • Improvements in migraine frequency, intensity, and disability were significantly correlated with increased GABA+ levels in the anterior cingulate cortex (ACC).
  • No significant correlation was observed between GABA+ levels and clinical improvements in the posterior cingulate gyrus (PCG).
  • Individuals treated with CGRP-monoclonal antibodies (CGRP-mAbs) showed a greater increase in ACC GABA+ and a reduction in migraine frequency compared to those not on CGRP-mAbs.

Conclusions:

  • The positive correlation between increased ACC GABA+ and improved migraine symptoms suggests GABA+ may act as a protective mechanism rather than a cause of migraine.
  • These findings challenge the notion of elevated GABA+ as a direct contributor to migraine pathophysiology.
  • The results imply that increased GABA+ could be the brain's attempt to suppress or mitigate migraine attacks.